Apoptosis of arterial cells induced by oxidized low density lipoproteins (OxLDL) is thought to contribute to the progression of atherosclerosis. However, most data on apoptotic effects and mechanisms of OxLDL were obtained with extensively oxidized LDL unlikely to occur in early stages of atherosclerotic lesions. We now demonstrate that mildly oxidized LDL generated by incubation with oxygen radical-producing xanthine/xanthine oxidase (X/XO) induces apoptosis in primary cultures of human coronary endothelial and SMC, as determined by TUNEL technique, DNA laddering, and FACS analysis. 
During atherogenesis, intimal macrophages and smooth muscle cells (SMC) take up large amounts of oxidized low density lipoproteins (OxLDL). Death of these cells then leads to the progressive formation of the necrotic core of atheromas (1) . Although necrosis induced by cytotoxicity accounts for some intimal cell death, programmed cell death may also play a role in the evolution of atherosclerosis (reviewed in ref 2) . Electron microscopy revealed characteristic features of apoptosis in atherosclerotic lesions, such as shrinkage of cell membranes, nuclear chromatin condensation, and formation of apoptotic bodies. The more sensitive and specific terminal deoxynucleotidyl transferase (TdT) -mediated dUTP nickend labeling (TUNEL) technique also indicated the presence of apoptotic cells in vivo (3, 4) . Other evidence includes the colocalization of caspase 3 and apoptotic cells in advanced human atherosclerotic plaques (5) , the presence of the proapoptotic factor Bax in intimal SMC (6) , and the expression of p53 in lesions (7) .
Increasing evidence suggests that oxidation of LDL may be responsible for apoptosis in the arterial wall. OxLDL is prevalent in atherosclerotic lesions (8) and promotes atherogenesis by enhancing uptake of OxLDL by macrophage scavenger receptors, promoting recruitment of circulating monocytes (9, 10) , and up-regulating chemotactic and growth-promoting factors in arterial cells (11) . OxLDL may also play an important role in initiating atherogenesis in human fetuses and in determining the rate of progression of atherosclerosis later in life (10, 12, 13) . Finally, OxLDL triggers humoral and cellular im-mune responses capable of modulating progression of atherosclerosis (14) .
OxLDL may induce apoptosis in all arterial cells (7, (15) (16) (17) (18) (19) (20) (21) . Some of the apoptotic mechanisms triggered by OxLDL have also been investigated. In vitro studies suggest an involvement of Fas receptors and ligands (20) , activation of caspase 3 (18) , downregulation of caspase inhibitors (21) , and activation of regulatory signal transducers, such as Bcl-2 (19, 22) , STAT (23) , and NFB (24, 25) , which may promote apoptosis or growth. Nevertheless, the biological relevance of apoptotic signaling pathways induced by OxLDL for the evolution of atherosclerotic lesions remains unknown, because the majority of previous studies used extensively oxidized LDL generated by incubation with micromolar concentrations of copper. However, levels of copper found in plasma and arteries are a million-fold smaller than those used in vitro (26) and the mechanisms actually inducing LDL oxidation in vivo are unknown. Furthermore, little is known about the degree of LDL modification in the arterial wall. LDL extracted from advanced, necrotic lesions showed extensive apolipoprotein fragmentation (8) , but the onset of apoptosis appears to occur in earlier stages of lesions (2) . It is therefore more likely that cells in early atherosclerotic lesions are mainly exposed to less extensively oxidized LDL.
The goal of the present study was to determine whether mildly oxidized forms of LDL may also trigger apoptosis in human endothelial cells and SMC and to explore oxygen radical-sensitive apoptotic signaling pathways activated by mildly oxidized LDL. We initially focused on apoptotic mechanisms established for extensively oxidized LDL (e.g., the Fas receptor pathway and the activation of caspases) and then investigated pathways not previously linked to oxidized LDL, such as tumor necrosis factor (TNF) receptors and the activation of MAP and Jun kinase-dependent transcription factors.
MATERIALS AND METHODS

LDL isolation and oxidation
Plasma was obtained from healthy nonsmoking males (nϭ6, age 23Ϯ5 years) and LDL was isolated by two rapid consecutive steps of ultracentrifugation in a KBr gradient, as described previously (27) . LDL (300 g/ml) was incubated for 12 h at 37°C with xanthine (2 mM final concentration) and xanthine oxidase (100 mU/ml, salicylate-free, from bovine milk, specific activity 1 U/mg of protein) in 0.150 M NaCl-0.01 M sodium phosphate (pH 7.4), as described previously in detail (27) (28) (29) (30) . The xanthine/xanthine oxidase (X/XO) reaction yields a short burst of superoxide radicals, singlet oxygen, and hydrogen peroxide, and therefore mimics oxygen radical generation in vivo. These radicals in turn generate hydroxyl radicals, which promote an oxidative chain reaction and further modification of LDL. Under the above conditions, only mildly oxidized LDL is generated ( Table 1 and refs [27] [28] [29] [30] . This mildly oxidized LDL differs from 'minimally' oxidized LDL, extensively oxidized LDL generated by incubation with copper ions (5 M for 24 h at 37°C), and other forms of chemically modified LDL in both the extent and the nature of modification. For example, when the incorporation of 14 C oleic acid into cholesteryl esters in resident peritoneal macrophages after 12 h was used as the index of 'bioactive' modification, this was 2.1 Ϯ 0.7* nmol/mg cell protein in native LDL, 12.3 Ϯ 0.9* in X/XO-LDL, 56.8 Ϯ 11.5**# in LDL oxidized for 24 h with 5 M copper, and 575 Ϯ 105 in acetylated LDL (*PϽ0.0001 and **PϽ0.001 vs. acetylated LDL; # PϽ0.001 vs. X/XO-LDL) (29) .
Actual superoxide radical production of the X/XO system was monitored in parallel experiments by following the reduction of cytochrome-c (1.2 mM) at 550 nm in a doublebeam spectrophotometer (Uvikon 810, Kontron, Zurich, Switzerland). This system generates ϳ20 nmol ϫ min/ml of superoxide radicals and ϳ40 nmol ϫ min/ml of hydrogen peroxide at peak activity (i.e., at 1.5 min) and then progressively declines within 6 min (28, 30) . An incubation time of 12 h was chosen because the peroxidative chain reaction initiated by X/XO continues to modify LDL long after the initial exposure to radicals generated by X/XO (28 -31) . Oxygen radical scavengers were added to the LDL solution immediately before adding X/XO. Superoxide dismutase (SOD), a superoxide scavenger, was added to a final concentration of 330 U/ml (28, 30) ; catalase, a hydrogen peroxide scavenger, was added to a final concentration of 1000 U/ml (28, 30) , and histidine, a scavenger of the singlet oxygen radical (32) to 10 mM. In all experiments, LDL was first oxidized with X/XO in the absence or presence of scavengers. Because oxygen radicals and scavengers may have direct effects on oxidation-dependent intracellular processes that may confound the effects of mildly oxidized LDL, X/XO-LDL was extensively dialyzed against phosphate-buffered saline (PBS) at 4°C before being incubated for 24 h with cells.
Cell cultures
Primary human coronary endothelial cells and SMC were cultured as described previously (33) . For FACS analysis experiments, cells were scraped, transferred into 15 ml Fal- 
a LDL was oxidized with X/XO and scavengers as described in Materials and Methods. Malondialdehyde content was determined as thiobarbituric acid reactive substances (TBARS) and relative electrophoretic mobility (REM) on agarose gel. SOD, superoxide dismutase; CAT, catalase; HIS, histidine. Data are mean Ϯ sd (nϭ6), # P Ͻ 0.001 vs. LDL; * P Ͻ 0.05 vs. X/XO-LDL; **P Ͻ 0.01 vs. X/XO-LDL; *** P Ͻ 0.001 vs. X/XO-LDL.
con tubes, and centrifuged at 1500 rpm for 5 min. Cell pellets were then twice resuspended in 3 ml PBS and centrifuged again under the same conditions.
DNA laddering
DNA fragmentation was assessed on agarose electrophoresis gels, as described (34) . Adherent and nonadherent cells were collected, washed twice with cold PBS, and resuspended in lysis buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 10 mM EDTA, 1% sodium dodecyl sulfate (SDS), and 0.1 mg/ml proteinase K. Cell suspensions were incubated at 4°C for 30 min and then centrifuged at 13,000 rpm for 10 min. Supernatants were extracted with 1:1 (v/v) phenol/ chloroform (24:1 isoamylic) and precipitated with 2.5 volumes of pure ethanol. DNA pellets were resuspended in Tris-EDTA buffer and applied to a 1.2% agarose gel in TBE.
TUNEL assay
Apoptosis in cultured cells was also assessed by the TUNEL technique, using the 'In situ cell death detection kit' (Boehringer Mannheim, Mannheim, Germany), as described (34) .
Flow-cytometric analysis
Cells were prepared as described above, DNA stained with 50 g/ml propidium iodide, and analyzed using a FACScan flow cytometer with fluorometric detection of both frontal and lateral diffusion (FACS VantageTM, Becton Dickinson, San Jose, Calif.) interfaced with a Hewlett Packard computer (34) . Cell cycle data analysis was performed with CELL-FIT software (Becton Dickinson). Cell distribution into different phases of the cell cycle was obtained by mathematical fitting of fluorometric histograms. Specifically, the first peak represents the fluorescence of cells in the G0/G 1 phase (diploid DNA), the second represents G2 and M phases (premitotic and mitotic phases, and thus tetraploid DNA), and cells in the S phase are distributed between the two major peaks. Apoptotic cells (breaking DNA) represent the Sub-G 1 phase and are localized before the first peak.
Fas and TNF receptor-mediated apoptosis
The contribution of the intramembrane Fas receptor to X/XO-LDL-mediated apoptosis was investigated by using a combination of two blocking goat polyclonal antibodies against the carboxyl and amino-terminal ends of human Fas ligand (FasL) (C20-G and Q20, respectively; Santa Cruz Biotechnology, Santa Cruz, Calif.). In addition, competition assays were carried out by adding the blocking antibody to FasL together with an agonistic rabbit polyclonal antibody against full-length human Fas (FL-335, Santa Cruz Biotechnology). The latter recognizes an epitope spanning from amino acids 1 to 335 of Fas and acts as ligand, activating Fas. Antibodies were added to 70% confluent cells in 6-well cell culture slides at 10 g/ml (C20 sc-957-G and Q20) or 100 g/ml (FL-335). Twenty minutes after addition of the blocking antibodies, native LDL, X/XO-LDL, or X/XO-LDL generated in the presence of scavengers was added and cells were incubated for 24 h at 37°C. As a control, an irrelevant (nonspecific) human IgG was used. Cells were then paraformaldehyde-fixed and incubated with TUNEL solution (see below).
The contribution of the two apoptotic TNF receptors, TNFRI and TNFRII, in X/XO-LDL-induced apoptosis was assessed in an analogous fashion by simultaneous use of 10 g/ml each of two blocking antibodies against TNFRI (C20 sc-1068) and TNFRII (L20, both from Santa Cruz Biotechnology). Since TNF may induce apoptosis by itself (35) , no competitive experiments with the ligand (TNF) were performed.
Western blot analysis
Whole-cell extracts were prepared as follows. Cells were scraped in cold PBS (4°C) and lysed in cold lysis buffer consisting of 0.5% Nonidet P-40 (Sigma, St. Louis, Mo.) in 50 mM HEPES (pH 7.5), 250 mM NaCl, 5 mM EDTA, 50 mM NaFl, 0.5 mM sodium orthovanadate, 0.5 mM phenylmethylsulfonyfluoride (PMSF), 5 g/ml aprotinin, and 5 g/ml leupeptin. Fifty micrograms of proteins separated by 12.5% SDS-polyacrylamide gel electrophoresis (PAGE) were transferred to Immobilon-P transfer membranes (Millipore) and Western blot analysis was performed according to standard procedures (36), modified as described previously (37 ). Optimal antibody concentrations were determined in pilot assays (usually 1:1000 dilution). Antibodies bound to their respective antigen in the membrane were visualized using species-specific monoclonal second antibodies against the Fab region of the primary antibody labeled with horseradish peroxidase. After adding substrate, luminescence was determined in an ECL luminometer (Amersham, Milan, Italy) and exposed to autoradiograph film (X-ray, Kodak) for 2 min. To ascertain that blots were loaded with equal amounts of protein lysates, membranes were also incubated with a polyclonal antibody against ␥ tubulin protein (Sigma).
Kinase assay
In contrast to all other experiments involving inhibitors or competitors, in the kinase assays cells were preincubated for 1 h with 50 g/ml of an inhibitor of the map kinase MEK1 (PD98059, Calbiochem Signal Transduction) or a blocking peptide against the carboxyl-terminal end of Jun kinase JKK1 (Cat. # 347-363, Calbiochem-Novabiochem Corporation). The culture medium was then changed, and X/XO-LDL prepared in the absence or presence of scavengers was added to control or MEK1 inhibitor-treated cells. After 24 h of incubation at 37°C, cells were lysed with lysis buffer (PBS containing 1% Nonidet NP-40 (Sigma, Aldrich), 0.5% sodium deoxycholate, 0.1% SDS, 100 g/ml protease inhibitor PMSF, 30 g/ml aprotinin A, and 100 mM sodium orthovanadate. Protein concentration was determined by Lowry assay. Kinase activity (38) was determined using the Kinase SPA Enzyme Assay system (Amersham, Little Chalfont, U.K.) as described (34) . Results were expressed as kinase activity. Zero activity was defined by cells treated with MEK1 inhibitor only.
Briefly, 400 g of protein were immunoprecipitated by incubating them for 60 min at 4°C with 1-2 g of the ERK1 and ERK2 antibodies for MAP-kinase activity and antibodies against the SAPK/JNK phospho-specific human domain for Jun-kinase activity (CALBIOCHEM). Immunoprecipitated proteins were collected and incubated overnight at 4°C with 20 g protein A Sepharose (Pharmacia-Biotech, Sweden). Pellets were resuspended in 25 l kinase buffer containing 50 mM HEPES (pH 7.5), 0.1 mM EDTA, 0.1 mg/ml BSA, 0.15 M NaCl, 0.1% mercaptoethanol. This was followed by addition of 5 g myeloblastic basic protein as substrate for MAP kinase and 5 mg of GST fusion protein of c-Jun as substrate for Jun-kinase (CALBIOCHEM), and of 10 l of ATP mix solution [930 l kinase buffer, 6 l 50 mM ATP (pH 7.0), 20 l 2 mM MgCl 2 , 44 l ␥P32-ATP (10 mCi/ml)]. After boiling for 5 min and SDS-PAGE, the incorporated radioactive phosphate was determined using a PhosphorImager (GS-525 Bio-Rad, Milan, Italy) interfaced with a Hewlett-Packard computer.
Nuclear extract preparation
Nuclear extracts were prepared as described previously (34) . Briefly, cells were disrupted by forced passage through a 26-gauge needle and nuclei were collected by centrifugation at 1500 rpm and resuspended in 1.2 volumes of an extraction solution consisting of 10 mM HEPES (pH 7.9), 0.4 M NaCl, 1.5 mM MgCl 2 , 0.1 mM ␤-aminoethyl-ether-N,N,NЈ,NЈ,-tetraacetic acid, 0.5 mM DTT, and 5% glycerol.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (2.5-5 g of proteins) were preincubated for 10 min at room temperature in 20 l of a solution consisting of 20 mM HEPES (pH 7.5), 40 mM KCl, and 5% glycerol containing 1 g poly(dI-dC) and 5 mM spermidine (34, 39) . Binding reactions were incubated for an additional 15 min with the following probes: consensus binding site for NFB (Cat. # sc-2511, Santa Cruz): 5Ј-AGTTGAGGGGACTTTC-CCAGGC-3Ј; binding site for AP-1 (# sc-2514, Santa Cruz): 5Ј-CGCTTGATGACTCAGCCGGAA-3Ј. Samples were then separated on 8% native PAGE.
RESULTS
Apoptotic effects of mildly oxidized LDL on endothelial and SMC
The apoptotic effects of LDL mildly oxidized with xanthine/xanthine oxidase (X/XO-LDL) on cultured human coronary artery endothelial cells and SMC were first tested by determining the percentage of TUNEL-positive nuclei and the degree of DNA fragmentation by agarose gel electrophoresis. Results for endothelial cells (Fig. 1, left) 
Involvement of Fas and TNF receptors
To investigate whether X/XO-LDL mediates cell death by ligand-mediated activation of apoptotic receptors of the TNF family (36), we first analyzed the contribution of Fas, an intramembrane domain that may trigger an apoptotic signal when activated by FasL (40, 41) . 
of apoptosis were induced by X/XO-LDL in cells preincubated with a nonspecific IgG. Preincubation with the anti-FasL antibody reduced TUNEL-positive cells induced by X/XO-LDL to about half, whereas a lesser degree of inhibition was seen for Cu 2ϩ -LDL. When cells were preincubated with a blocking antibody to FasL together with an agonistic antibody to Fas itself (which activates Fas), no inhibition of apoptosis was seen. A significant albeit relatively smaller antiapoptotic effect of the antibody to FasL was also seen in cells incubated with mildly oxidized LDL generated in the presence of SOD, catalase, or a combination thereof. Together, these data indicate that ϳ50% of the apoptotic effect of mildly oxidized LDL is mediated by the Fas receptor.
We then investigated the role of TNF receptors by using blocking antibodies against the two apoptotic members of the TNF receptor family, TNFRI and TNFRII (41, 42) . As shown in Fig. 3 , only the simultaneous blockage of both TNFRI and TNFRII significantly inhibited the apoptotic effect of mildly oxidized LDL. Results for Cu 2ϩ -LDL were similar. This shows that both receptors are involved in apoptosis. However, antibody blocking only led to a 20% reduction of TUNEL-positive cells induced by both forms of oxidized LDL. Simultaneous addition of blocking antibodies to FasL, TNFRI, and TNFRII resulted in a 70% reduction of apoptosis (data not shown). Together, these experiments indicate that apoptosis of endothelial cells and SMC induced by Cu 2ϩ -LDL or mildly oxidized LDL is mediated by the Fas receptor and, to a lesser degree, receptors of the TNF receptor family.
The contribution of the Fas receptor was also investigated by FACS. Without blocking antibody to FasL, incubation of endothelial cells with X/XO-LDL resulted in ϳ95% apoptotic cells, i.e., cells in the Sub G-1 phase. In the presence of the antibody, apoptotic cells were reduced to 69%. Accumulation of apoptotic cells in the Sub-G1 fraction did not block cell cycle progression. The presence of scavengers during the generation of X/XO-LDL markedly decreased the percentage of apoptotic cells, and the protective effect of different scavengers was cumulative. When measured by FACS, the reduction of X/XO-LDL-induced apoptosis by the blocking antibodies was smaller than the reduction measured by TUNEL. For example, simultaneous addition of blocking antibodies to FasL, TNFRI, and TNFRII caused a 42% (range 27-56%) reduction of Sub-G1 cells but an ϳ70% reduction of apoptosis measured by TUNEL (data not shown). In most of the following experiments, results obtained by TUNEL were 
Activation of caspases
Upon ligand activation and oligomerization of the Fas and TNF receptors, their intracellular death domains interact with adaptor molecules containing death effector domains or caspase activation and recruitment domains, such as Fas-associated death domain (41, 42) . These in turn trigger the activation of caspases, the major effectors of apoptosis. To determine whether X/XO-LDL-induced activation of apoptotic receptors leads to caspase activation, two class I caspases (caspases 2 and 8) and two class II caspases (caspases 3 and 6) were analyzed by Western blot (Fig. 4) . Incubation with mildly oxidized LDL resulted in increased presence of active subunits of both class I caspases (thought to be the activators of class II caspases) and class II caspases (thought to be the main proteolytic effectors). The presence of scavengers during the incubation of LDL with X/XO markedly reduced caspase activation.
The activation of the caspase substrate poly (ADPribose) polymerase (PARP) was also determined as another indicator of the involvement of the caspase pathway in X/XO-LDL-induced apoptosis. PARP was markedly increased in cells exposed to X/XO-LDL; its level remained high even when X/XO-LDL had been generated in the presence of scavengers (Fig. 4,  bottom) , suggesting the increased PARP expression is induced by minimum apoptotic stress. Very similar results were obtained with Cu 2ϩ -LDL (data not shown).
Pro-and antiapoptotic proteins of the Bcl-2 family
While caspase activation through recruitment of procaspases and dimerization constitutes a major pathway of apoptosis induced by Fas or TNF receptor activation, caspase activation is also induced by members of the Bcl-2 family of proteins. These proteins either promote (Bax) or inhibit (Bcl-2) apoptosis and work in conjunction with a distinct ATPase to activate specific caspases (42) . Pro-and antiapoptotic members of this family antagonize each other by forming heterodimers (41) . To determine whether mildly oxidized LDL may also influence apoptosis via Bax/Bcl-2-regulated mechanisms, we investigated the effects of X/XO-LDL and scavengers on Bax, Bcl-2 and Bad (Fig. 5) . In endothelial cells, there was a marked decrease in the antiapoptotic Bcl-2 protein after incubation with X/XO-LDL, which was reduced by the presence of scavengers during LDL oxidation. No effect of X/XO-LDL on Bax was noticeable. In contrast, Bad, which also antagonizes Bcl-2 and induces apoptosis through cytochrome c-independent activation of caspases (42), was markedly increased by X/XO-LDL and its up-regulation reduced by scavengers (Fig. 5) . No changes in Bcl-2 proteins were apparent in SMC. These results suggest that in endothelial cells, mildly oxidized LDL may also contribute to apoptosis by shifting the equilibrium between pro-and antiapoptotic members of the Bcl-2 family. Very similar results were obtained with Cu 2ϩ -LDL (data not shown).
Activation of MAP and Jun kinase pathways
The transduction of apoptotic signals to the nucleus may also be mediated by activation of MAP kinases, which in turn may activate Jun kinase (43) . Together, MAP and Jun kinases form a complex regulatory system interposed between cytokine-induced activation of cell membrane receptors and downstream signaling factors (38, 44) . As shown in Fig. 6 , MAP-kinase activity in SMC incubated with Cu 2ϩ -LDL and X/XO-LDL was about 12-fold and 9-fold greater than that in cells incubated with native LDL, respectively. Addition of X/XO-LDL prepared in the presence of scavengers resulted in lesser increases (approximately half for X/XO-LDL plus SOD or CAT) or no increase of MAP kinase activity (for X/XO-LDL plus SOD, CAT, and histidine). In each case, preincubation of cells with a MEK1 inhibitor significantly reduced MAP kinase activity induced by Cu 2ϩ -LDL or X/XO-LDL Ϯ scavengers, compared to the respective control. More important, TUNEL analysis indicated that the MEK1 inhibitor significantly reduced SMC apoptosis (e.g., by 67.6Ϯ6.8% in cells incubated with X/XO-LDL and 52.4% in cells incubated with Cu 2ϩ -LDL). Similar results were obtained in endothelial cells (not shown). These data indicate that the MAP kinase pathway plays an important role in mediating apoptosis induced by both forms of oxidized LDL.
Jun, one of the downstream effectors of MAP kinase (43, 44) should also be activated by X/XO-LDL. Indeed, Western blot analysis revealed a marked increase in the active, phosphorylated form of Jun protein (pc-Jun) in endothelial cells, compared to controls incubated with native LDL (Fig.  7A) . X/XO-LDL prepared in the presence of scav- engers induced markedly less Jun activation. The amount of c-Jun protein also appeared increased in cells incubated with X/XO-LDL. Blocking of the Jun kinase JKK1 significantly reduced apoptosis (Fig.  7B) . The degree of reduction was limited, perhaps because of limited cell penetration of the blocking peptide, but inhibition of Jun kinase was dose dependent (data not shown). Direct measurements of Jun kinase activity also indicated that X/XO-LDL significantly increased Jun kinase activity, compared to native LDL (3.5Ϯ0.8 arbitrary units vs. 1.1Ϯ0.5; PϽ0.001), and that scavengers progressively reduced it (Fig. 7C) . Similar results were obtained with Cu 2ϩ -LDL (Fig. 7A-C) .
Nuclear presence of MAP and Jun dependent transcription factors
To further study the involvement of the kinase pathway in apoptosis induced by mildly oxidized LDL, several kinase-dependent factors were investigated in nuclear extracts. These included the apoptotic factor p53 (activated by the MKK4-JNK1 pathway), ELK-1 (activated by either the MAP-MEK1-ERK-1 or MKK3-p38 pathway), and the ATF-2/CREB family (activated by either the MKK4-JNK1-3 or MEK3-p38 pathways) (44) . As shown in Fig. 8 , the active (phosphorylated) forms of p53, ATF-2, ELK-1 and p-CREB were all markedly increased by X/XO-LDL and their up-regulation was progressively reduced by scavengers. Virtually identical results as for X/XO-LDL were obtained with Cu 2ϩ -LDL (data not shown).
Activation of NFB and AP-1 complex
Extensively oxidized LDL has previously been shown to enhance phosphorylation of IB␣ in mononuclear phagocytes (24) . The effect of X/XO-LDL and oxygen radical scavengers on NFB was investigated by EMSA of nuclear extracts (Fig. 9A) . In both SMC and endothelial cells, X/XO-LDL induced increased NFB activity. Western blot analysis of nuclear extracts also showed a direct effect of mildly OxLDL on IB␣/NFB proteins (Fig. 9B) . NFB was increased in cells exposed to X/XO-LDL. In parallel, IB␣ was markedly reduced in cells incubated with X/XO-LDL. These effects were partially prevented by scavengers. Similar results as for X/XO-LDL were obtained with Cu 2ϩ -LDL (data not shown). Because AP-1 is selectively activated by the JNK1-3 pathway, this provides additional evidence for Jun kinase activation by mildly oxidized LDL or Cu 2ϩ -LDL (Fig. 9C ).
DISCUSSION
Our study provides the most extensive investigation of the effects of oxidized LDL on apoptotic signaling pathways to date and indicates for the first time that OxLDL-induced apoptosis involves TNF receptors and Jun activation. More important, it demonstrates that mildly oxidized LDL likely to be prevalent in earlier stages of atherosclerotic lesions is capable of inducing apoptosis in human coronary artery endothelial cells and SMC by activating multiple oxygen radical-sensitive signaling pathways.
Extensively oxidized LDL has previously been shown to trigger apoptosis of endothelial cells (18 -21) , SMC (17) , macrophages (7, 15) , and lymphocytes (22) . However, the pathophysiological relevance of OxLDL-induced apoptosis in the arterial wall remained uncertain, because extensively oxidized LDL is unlikely to be formed in transitional lesions, where apoptosis begins (2) .
Our results demonstrated that up to 70% of apoptosis induced by mildly oxidized LDL was mediated by receptors of the TNF receptor family and that both Fas and TNF receptors I and II were involved. To date, only the involvement of the Fas pathway in OxLDL-induced apoptosis had been reported. In fact, copper-oxidized LDL up-regulated endothelial expression of FasL (but not Fas) and apoptosis was reduced in endothelial cells from knockout mice lacking either FasL or Fas (20) . Our experiments with blocking antibodies to FasL and Fas suggest that mildly oxidized LDL also acts mainly by up-regulating expression of FasL. Activation of the Fas pathway results in oligomerization of Fas (41) and recruitment of FADD and FADD homologous, ICE-like protease (FLICE), which then activate caspases. The observation that the FLICE inhibitory protein (which inhibits caspase activation by binding to FLICE) is down-regulated by OxLDL further supports the involvement of the Fas pathway in OxLDLinduced apoptosis (21) . As shown in Fig. 3 , TNF receptors I and II are also involved in OxLDLinduced apoptosis. Although the TNF receptors seemed to play a lesser role than Fas/FasL, our findings are consistent with the immunohistochemical observation that apoptotic cells, OxLDL, and TNF-␣ colocalize in atherosclerotic lesions (17) and that TNF-␣ induces apoptosis in SMC (17) and macrophages (7) .
As shown in Fig. 4 , mildly oxidized LDL induced activation of two class I caspases (caspases 2 and 8), as well as two class II caspases (3 and 6). To date, an effect of extensively oxidized LDL had only been reported for caspases 1 and 3 (18, 46) . PARP, a caspase substrate, also was increased by mildly oxidized LDL. This suggests that caspase activation plays a major role in oxidation-induced apoptosis, a conclusion also supported by the fact that inhibitors of caspases 1 and 3 reduced apoptosis induced by extensively oxidized LDL in human umbilical vein endothelial cells (46) . Proteins of the Bcl-2 family are important regulatory elements for caspase activation and apoptosis (19, 41, 46) . Incubation of endothelial cells (but not SMC) with X/XO-LDL increased proapoptotic Bad (Fig. 5 ) and decreased antiapoptotic Bcl-2 protein. Thus, mildly oxidized LDL seems to induce 'dynamic movements' in these regulatory proteins. Extensively oxidized LDL appeared not to affect Bax (21) . However, both the absolute amount of proteins of the Bcl-2 family and their intracellular location may be as important for apoptosis as their overall cellular content. Cultured cardiomyocytes exposed to oxygen radicals showed increased Bad and unchanged Bax and Bcl-2 expression, but superoxide treatment elicited translocation of Bax and Bad from the cytosol into mitochondria (47) .
Another apoptotic mechanism induced by mildly oxidized LDL was the activation of MAP and Jun kinases (for background, see ref 44) . MAP kinase activity induced by mildly oxidized LDL was significantly decreased by a MEK1 inhibitor, consistent with a previous report on the effects of extensively oxidized LDL on MAP kinases (48) . In addition, our results show that mildly oxidized LDL also activates Jun and that Jun activation contributes to programmed cell death (Fig. 7) . The fact that scavengers greatly reduced activation of MAP and Jun kinases indicates the involvement of oxygen radicals in these processes. Mildly oxidized LDL also increased expression of factors p53, the ATF-2/CREB family, ELK-1, and AP-1. This may merely reflect activation of MAP and Jun kinases. On the other hand, some of the above factors may actively promote apoptosis. For example, phosphorylated forms of ATF-2 and c-Jun (via the MEKK1 pathway) induce FasL expression (44, 49) . It is therefore possible that activation of ATF-2 contributes to the up-regulation of FasL discussed above, but other proapoptotic effects cannot be ruled out. For example, the DNA binding protein p53 also triggers apoptosis (50) , but no effect of p53 on FasL has been reported.
Together, our data indicate that mildly oxidized LDL up-regulates FasL and TNF receptors I and II and induces cell death by activation of the caspase cascade, which may be increased by a shift toward proapoptotic proteins of the Bcl-2 family. However, we do not know whether the enhanced expression of apoptotic receptors in cultured cells is a direct effect of mildly oxidized LDL or whether it is secondary to cytokine responses triggered by effects of OxLDL on the cell membrane or intracellular effects of oxygen radicals.
Although our results and those of others indicate that OxLDL also induces activation of NFB, the role of this nuclear transcription factor in apoptosis is not well understood. The observation that antioxidants inhibit expression of NFB-regulated cytokines, such as VCAM-1, in vivo (51) supports the role of oxidation in the up-regulation of NFB. If one accepts an antiapoptotic role of NFB, its activation by mildly oxidized LDL may indicate that OxLDL can both promote and inhibit apoptosis by different pathways (52) . It may also indicate that proapoptotic effects trigger a protective reaction via NFB activation.
Mildly oxidized LDL generally had similar apoptotic effects on SMC and endothelial cells. However, cell culture studies may not necessarily reflect apoptotic mechanisms in humans (2, 53) , much less actual cell death by apoptosis in the arterial wall. It can safely be assumed that LDL oxidized to a similar mild degree as X/XO-LDL (or X/XO-LDL prepared in the presence of scavengers) is present in both early and transitional atherosclerotic lesions. Indeed, oxidation-specific epitopes are already present in the earliest fatty streaks of premature human fetuses and children (10, 12, 13) , as well as in animal models. In contrast, apoptosis seems to occur only in transitional and more advanced lesions. Our results should therefore be considered as evidence for the interference of mildly oxidized LDL in a broad range of intracellular signaling processes, rather than induction of actual cell death. In most cases, we found only quantitative differences in the apoptotic mechanisms induced by Cu 2ϩ -LDL and X/XO-LDL, even though the difference in the degree of ex vivo oxidative modification was substantial. Our data support the concept that extensive oxidative modifications of LDL are not necessary to influence a cascade of signaling events in vivo.
The biological importance of LDL oxidation is not limited to the induction of apoptosis. It is increasingly recognized that OxLDL may also modulate the evolution of atherosclerosis by enhancing expression of cytokines and growth factors via NFB by down-regulating proinflammatory genes through the peroxisome proliferator-activated receptor ␥ (54), altering the activity of the proteasome pathway (55) , and by inducing persistent changes in the arterial wall during fetal development that determine the rate of lesion progression later in life (13) . Oxygen radicals may interfere with many of these mechanisms (52) , and LDL oxidation is not the sole source of peroxidative compounds. Increased formation of oxygen radicals and oxidative compounds in the arterial wall also can result from myocardial reperfusion injury or other inflammatory conditions (30, 37) . The observation that the scavengers used in the present study had qualitatively similar synergistic effects indicates that different oxygen radicals have analogous effects on signaling pathways. Antioxidants such as vitamin E (34) and C (56) may reduce the degree of apoptosis induced by oxidized LDL. It is therefore likely that even mild shifts in oxidation within the arterial wall may profoundly influence the evolution of atherosclerosis by activating multiple regulatory pathways and nuclear transcription factors. C.N. would like to dedicate this study to the memory of Dr. Gaetano Salvatore. We regret that for reasons of brevity many relevant original papers could not be quoted. The studies were supported by NHLBI grant HL56989 (La Jolla SCOR in Molecular Medicine and Atherosclerosis), CNR grant 99.00198, MURST grant 96/40%, and ISNIH grant 56980/99.
